Medicinal Products

Runaplax 15 mg filmom obložene tablete

Name Runaplax 15 mg filmom obložene tablete
Marketing Authorisation Number HR-H-918282060
Active Substance rivaroksaban
Composition svaka filmom obložena tableta sadrži 15 mg rivaroksabana
Pharmaceutical Form filmom obložena tableta
Packaging [MA Number for Packaging] 5 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-918282060-01]
10 tableta u blisteru, u kutiji  [HR-H-918282060-02]
10 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-918282060-03]
14 tableta u blisteru s jediničnom dozom, u kutiji  [HR-H-918282060-04]
20 tableta u blisteru, u kutiji  [HR-H-918282060-05]
28 tableta u blisteru, u kutiji  [HR-H-918282060-06]
30 tableta u blisteru, u kutiji  [HR-H-918282060-07]
42 tablete u blisteru, u kutiji  [HR-H-918282060-08]
50 tableta u blisteru, u kutiji  [HR-H-918282060-09]
98 tableta u blisteru, u kutiji  [HR-H-918282060-10]
100 tableta u blisteru, u kutiji  [HR-H-918282060-11]
100 tableta u bočici, u kutiji  [HR-H-918282060-12]
Manufacturer Salutas Pharma GmbH, Barleben, Njemačka
Marketing Authorisation Holder Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska
Marketing Authorisation Date 10.10.2022
MA Period of Validity unlimited
Classification Number UP/I-530-09/21-02/193
Registration Number 381-12-01/154-22-03
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code B01AF01
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Vodič za liječnike s informacijama o primjeni rivaroksabana, verzija 1
Educational materials
for patients / caregivers
Kartica s upozorenjima za bolesnika Runaplax
Back